Literature DB >> 15593317

Mutant torsinA, which causes early-onset primary torsion dystonia, is redistributed to membranous structures enriched in vesicular monoamine transporter in cultured human SH-SY5Y cells.

Anjum Misbahuddin1, Mark R Placzek, Jan-Willem Taanman, Steve Gschmeissner, Giampietro Schiavo, J Mark Cooper, Thomas T Warner.   

Abstract

A single GAG deletion in the DYT1 gene causes primary early-onset, generalized torsion dystonia. The DYT1 protein product, torsinA, belongs to the AAA+ family of proteins. When overexpressed, wild-type torsinA localizes mainly to the endoplasmic reticulum, whereas the mutant forms inclusions of unclear biogenetic origin. In this study, overexpressed wild-type torsinA in human neuroblastoma (SH-SY5Y) cell lines was distributed throughout the cell body and colocalized with a marker for the endoplasmic reticulum, confirming it is an endoplasmic reticulum protein. However, mutant torsinA showed perinuclear staining and formed distinct globular inclusions, which did not colocalize with endoplasmic reticulum markers. Immunoelectron microscopy of the mutant torsinA inclusions revealed membrane whorls staining for torsinA, as well as labeling of lamellae, isolated bilayers, and perinuclear membranes. This finding shows that mutant torsinA redistributes to specific membranous structures, which may represent different stages of maturation of the intracellular inclusions. The mutant torsinA-containing bodies were immunoreactive for vesicular monoamine transporter 2 (VMAT2). VMAT2 expression is important for the exocytosis of bioactive monoamines in neurons. Abnormal processing, transport, or entrapment of VMAT2 within the mutant torsinA membranous inclusions, therefore, may affect cellular dopamine release, providing a potential pathogenic mechanism for the DYT1-dependent dystonia. Copyright 2004 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15593317     DOI: 10.1002/mds.20351

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  21 in total

Review 1.  Genetic and clinical features of primary torsion dystonia.

Authors:  Laurie J Ozelius; Susan B Bressman
Journal:  Neurobiol Dis       Date:  2010-12-17       Impact factor: 5.996

Review 2.  Primary dystonia: molecules and mechanisms.

Authors:  Lauren M Tanabe; Connie E Kim; Noga Alagem; William T Dauer
Journal:  Nat Rev Neurol       Date:  2009-10-13       Impact factor: 42.937

3.  Dysregulation of striatal dopamine release in a mouse model of dystonia.

Authors:  Li Bao; Jyoti C Patel; Ruth H Walker; Pullanipally Shashidharan; Margaret E Rice
Journal:  J Neurochem       Date:  2010-07-27       Impact factor: 5.372

Review 4.  Molecular pathways in dystonia.

Authors:  D Cristopher Bragg; Ioanna A Armata; Flavia C Nery; Xandra O Breakefield; Nutan Sharma
Journal:  Neurobiol Dis       Date:  2010-12-04       Impact factor: 5.996

5.  CSN complex controls the stability of selected synaptic proteins via a torsinA-dependent process.

Authors:  Alessandra Granata; Seong Joo Koo; Volker Haucke; Giampietro Schiavo; Thomas T Warner
Journal:  EMBO J       Date:  2010-11-19       Impact factor: 11.598

6.  Abnormal motor function and dopamine neurotransmission in DYT1 DeltaGAG transgenic mice.

Authors:  Yu Zhao; Michael DeCuypere; Mark S LeDoux
Journal:  Exp Neurol       Date:  2008-01-19       Impact factor: 5.330

7.  The ubiquitin ligase F-box/G-domain protein 1 promotes the degradation of the disease-linked protein torsinA through the ubiquitin-proteasome pathway and macroautophagy.

Authors:  K L Gordon; K A Glenn; N Bode; H M Wen; H L Paulson; P Gonzalez-Alegre
Journal:  Neuroscience       Date:  2012-08-20       Impact factor: 3.590

Review 8.  Emerging common molecular pathways for primary dystonia.

Authors:  Mark S Ledoux; William T Dauer; Thomas T Warner
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

Review 9.  Commentary: Dopaminergic dysfunction in DYT1 dystonia.

Authors:  Thomas Wichmann
Journal:  Exp Neurol       Date:  2008-04-26       Impact factor: 5.330

10.  Mutant torsinA interferes with protein processing through the secretory pathway in DYT1 dystonia cells.

Authors:  Jeffrey W Hewett; Bakhos Tannous; Brian P Niland; Flavia C Nery; Juan Zeng; Yuqing Li; Xandra O Breakefield
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.